Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gillian H Lim"'
Autor:
Shinthuja Wijayasri, Kelty Hillier, Gillian H Lim, Tara M Harris, Sarah E Wilson, Shelley L Deeks
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226353 (2019)
BACKGROUND:Ontario, Canada introduced a publicly-funded 13-valent pneumococcal conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009-2010) and the 7-valent (PCV7, 2005-2009) conjugate vaccine programs; a 23-valent pneumo
Externí odkaz:
https://doaj.org/article/3a59a5c3166641dc897def673b4c1008
Autor:
Natasha S. Crowcroft, Gillian H. Lim, Shelly Bolotin, Shelley L. Deeks, Ye Li, Jane M. Heffernan, Fiona M. Guerra
Publikováno v:
The Lancet Infectious Diseases. 17:e420-e428
Summary The basic reproduction number, R nought (R 0 ), is defined as the average number of secondary cases of an infectious disease arising from a typical case in a totally susceptible population, and can be estimated in populations if pre-existing
Autor:
Raymond S. W. Tsang, Jennifer L. Guthrie, Alex Marchand-Austin, Jennifer Ma, Shelley L. Deeks, Natasha S. Crowcroft, Gillian H. Lim, David J. Farrell, Frances B. Jamieson
Publikováno v:
Journal of Clinical Microbiology. 55:1446-1453
Bordetella pertussis is a Gram-negative bacterium that causes respiratory infections in humans. Ongoing molecular surveillance of B. pertussis acellular vaccine (aP) antigens is critical for understanding the interaction between evolutionary pressure
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226353 (2019)
PLoS ONE
PLoS ONE
Background Ontario, Canada introduced a publicly-funded 13-valent pneumococcal conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009–2010) and the 7-valent (PCV7, 2005–2009) conjugate vaccine programs; a 23-valent pn
Autor:
Gillian H. Lim, Sarah E. Wilson, Shelley L. Deeks, Jill Fediurek, Natasha S. Crowcroft, Chi Yon Seo
Publikováno v:
CMAJ Open. 3:E317-E323
Results: For both 7- and 17-year-old students, religious or conscientious exemptions for measles-containing vaccines significantly increased over the study period (p < 0.001 in both age groups), whereas medical exemptions decreased (p < 0.001 in both
Publikováno v:
Canada Communicable Disease Report. 40:143-151
Background Under the guidance of the Pan American Health Organization (PAHO), countries of the Americas are currently documenting the elimination of measles, rubella, and congenital rubella syndrome. Objective This paper describes Ontario's progress
Publikováno v:
Relevé des maladies transmissibles au Canada. 40:162-171
Autor:
Jill Fediurek, C Walker, Gillian H. Lim, Shelley L. Deeks, Natasha S. Crowcroft, J Walters, F Lam, R Walton
Publikováno v:
Canada Communicable Disease Report. 40:42-49
Background A prolonged pertussis outbreak began in Ontario in November 2011 in an under-immunized religious community and subsequently spread to the general population and a second religious community in the same region of the province. Objective To
Autor:
N.S. Crowcroft, Jill Fediurek, F Lam, S.L. Deeks, C Walker, J Walters, R Walton, Gillian H. Lim
Publikováno v:
Relevé des maladies transmissibles au Canada. 40:43-50
Autor:
Karen Green, Shelley L. Deeks, Jonathan B. Gubbay, Dylan R. Pillai, Don E. Low, Natasha S. Crowcroft, Gillian H. Lim, Wallis Rudnick, Anne E Wormsbecker, Allison McGeer
Publikováno v:
Vaccine. 31:2680-2685
Publicly funded infant 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in Ontario, Canada in 2005 and was replaced by 10- and 13-valent vaccines (PCV10, PCV13) in October 2009 and November 2010, respectively. Among adults ≥ 65 years,